Financings in Brief: UroHealth Systems
This article was originally published in The Gray Sheet
Executive Summary
UroHealth Systems: Manufacturer of urological, gynecological, and general surgery products completes $50 mil. placement of convertible debentures through agents Bear Stearns, Piper Jaffray, and Needham & Co. The debentures pay a quarterly dividend at an annual rate of 8.75% and are convertible at $11 into common stock, the firm says. Proceeds will provide the Newport Beach, California company with "the capital necessary to pay off existing debt and to continue to aggressively pursue our growth strategy"...